SF-36 components | β |
p
|
---|
PFa
| 0.057 | 0.471 |
RPb
| -0.018 | 0.836 |
BPc
| -0.060 | 0.383 |
GHd
| -0.016 | 0.067 |
VTe
| -0.097 | 0.255 |
SFf
| -0.204 | 0.012 |
REg
| -0.151 | 0.091 |
MHh
| -0.068 | 0.397 |
PCSi
| -0.045 | 0.527 |
MCSg
| -0.158 | 0.037 |
-
p values were obtained with multiple linear regression analysis
-
acontrolled for income, disease duration, ESR, CRP, DAS28, total pain, nocturnal pain, HAQ-DI, and HADS. bcontrolled for income, synthetic DMARDs, CRP, DAS28, total pain, nocturnal pain, HAQ-DI, and HADS. ccontrolled for income, synthetic DMARDs, CRP, RF, DAS28, total pain, nocturnal pain, HAQ-DI, and HADS. dcontrolled for age, alcohol, disease duration, synthetic DMARDs, DAS28, total pain, nocturnal pain, HAQ-DI, and HADS. econtrolled for income, disease duration, ESR, CRP, DAS28, total pain, nocturnal pain, HAQ-DI, and HADS. fcontrolled for age, income, synthetic DMARDs, ESR, CRP, RF positive, anti-CCP positive, DAS28, total pain, nocturnal pain, HAQ-DI, and HADS. gcontrolled for age, income, synthetic DMARDs, ESR, CRP, RF positive, DAS28, total pain, nocturnal pain, HAQ-DI, and HADS. hcontrolled for occupation, income, ESR, CRP, DAS28, total pain, nocturnal pain, HAQ-DI, and HADS. icontrolled for income, disease duration, synthetic DMARDs, ESR, CRP, DAS28, total pain, nocturnal pain, HAQ-DI, and HADS